FindTrial
Sign In

An objective diagnostic paradigm for breast cancer-related Liver qi depression and its concurrent syndromes via deep-learning-based cross-modal attention fusion

An objective diagnostic paradigm for breast cancer-related Liver qi depression and its concurrent syndromes via deep-learning-based cross-modal attention fusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000455
Enrollment
Unknown
Registered
2026-03-03
Start date
2026-03-02
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Breast cancer with Liver qi depression:None
Breast cancer-related Liver qi depression with concurrent syndrome:None
Breast cancer without Liver qi depression:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Histopathologically confirmed diagnosis of malignant breast tumor; (2) Female patients aged 18–70 years; (3) Eastern Cooperative Oncology Group (ECOG) performance status 0–2; (4) Willing to participate, able to comply with study procedures, and have provided written informed consent.

Exclusion criteria

Exclusion criteria: (1) Concomitant other malignant tumors; (2) Severe primary diseases of the liver, kidney, or hematopoietic system; (3) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Inspection;Tongue examination;Palpation;Transcriptomics;—

Countries

China

Contacts

Public ContactQianjun Chen

Guangdong Provincial Hospital of Chinese Medicine

cqj55@163.com18688883505

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026